Kenvue company profile
Company profile
Kenvue has 21,780 employees and is headquartered in Summit, United States.
Consumers in the United States, the rest of North America, Europe, the Middle East, Africa, Asia-Pacific and Latin America are the markets served by Kenvue, a consumer health company. Its three segments are Self Care, Skin Health and Beauty, and Essential Health, covering over-the-counter medicines, skin and hair care, sun products, oral and baby care, women's health, wound care, tampons, cosmetics and vitamins. Brands in the portfolio include Tylenol, Neutrogena, Johnson's, Listerine, Zyrtec and BAND-AID.
In the fiscal year ended December 2025, revenue reached 15.1 billion dollars, down 2.1% from the previous year, and net income was 1.5 billion dollars. North America accounted for 48.0% of revenue, with the United States alone at 42.7% and Latin America at 9.1%. Formerly known as JNTL, Inc., the company was incorporated in 2022 and employs 21,780 people, with headquarters in Summit, New Jersey.
Company facts
- Sector
- Consumer
- Industry
- Household & Personal Products
- Country
- United States
- Headquarters
- 1 Kenvue Way, 07901, Summit
- Employees
- 21,780
- Chief executive
- Kirk Perry
- Founded
- 2022
- Fiscal year
- January - December
- Listing
- KVUE · NYSE
- Currency
- USD
- ISIN
- US49177J1025
- Website
- kenvue.com
Kenvue and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| KenvueKVUE | United States | $37.11B | 21,780 | 19.2% | 21.9 |
| Estée Lauder CompaniesEL | United States | $39.35B | 37,950 | 11.9% | 108.6 |
| Church And DwightCHD | United States | $27.08B | 5,550 | 18.6% | 35.2 |
| Kimberly-ClarkKMB | United States | $68.33B | 36,000 | 17.3% | 21.2 |
| Colgate-PalmoliveCL | United States | $79.18B | 33,600 | 20.7% | 38.8 |
| CloroxCLX | United States | $12.93B | 9,200 | 14.3% | 19.2 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
